PL405111A1 - Dojelitowa tabletka duloksetyny - Google Patents

Dojelitowa tabletka duloksetyny

Info

Publication number
PL405111A1
PL405111A1 PL405111A PL40511113A PL405111A1 PL 405111 A1 PL405111 A1 PL 405111A1 PL 405111 A PL405111 A PL 405111A PL 40511113 A PL40511113 A PL 40511113A PL 405111 A1 PL405111 A1 PL 405111A1
Authority
PL
Poland
Prior art keywords
tablet
core
duloxetine
tableting
copolymer
Prior art date
Application number
PL405111A
Other languages
English (en)
Other versions
PL224543B1 (pl
Inventor
Jolanta Trela
Ewelina Kowalska
Original Assignee
Pabianickie Zakłady Farmaceutyczne Polfa Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52483131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL405111(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pabianickie Zakłady Farmaceutyczne Polfa Spółka Akcyjna filed Critical Pabianickie Zakłady Farmaceutyczne Polfa Spółka Akcyjna
Priority to PL405111A priority Critical patent/PL224543B1/pl
Priority to MYPI2016000205A priority patent/MY190111A/en
Priority to SG11201600886YA priority patent/SG11201600886YA/en
Priority to AU2014310317A priority patent/AU2014310317B2/en
Priority to EP14790300.9A priority patent/EP3035919B1/en
Priority to EA201690368A priority patent/EA029916B1/ru
Priority to MX2016002269A priority patent/MX2016002269A/es
Priority to HK16112510.8A priority patent/HK1224197A1/zh
Priority to PCT/IB2014/063955 priority patent/WO2015025261A1/en
Priority to UAA201602494A priority patent/UA119852C2/uk
Publication of PL405111A1 publication Critical patent/PL405111A1/pl
Priority to PH12016500245A priority patent/PH12016500245A1/en
Priority to ZA2016/01724A priority patent/ZA201601724B/en
Publication of PL224543B1 publication Critical patent/PL224543B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)

Abstract

Wynalazek dotyczy dojelitowej tabletki duloksetyny oraz sposobu jej wytwarzania. Tabletka składa się z rdzenia, w którym chlorowodorek duloksetyny jest jednorodnie wymieszany z cukrem do tabletkowania oraz ewentualnie jedną lub więcej substancji pomocniczych oraz powłoki dojelitowej nałożonej bezpośrednio na rdzeń i zawierającej kopolimer kwasu metakrylowego z akrylanem etylu (1:1) jako jedyny polimer odporny na działanie kwasu żołądkowego. Dojelitową tabletkę wytwarza się przez tabletkowanie mieszanki uprzednio przygotowanej bez użycia jakichkolwiek cieczy oraz bezpośrednie nałożenie na rdzeń powłoki dojelitowej z kopolimerem kwasu metakrylowego z akrylanem etylu 1:1.
PL405111A 2013-08-21 2013-08-21 Dojelitowa tabletka duloksetyny PL224543B1 (pl)

Priority Applications (12)

Application Number Priority Date Filing Date Title
PL405111A PL224543B1 (pl) 2013-08-21 2013-08-21 Dojelitowa tabletka duloksetyny
UAA201602494A UA119852C2 (uk) 2013-08-21 2014-08-18 Таблетка дулоксетину з ентеросолюбільним покриттям
MX2016002269A MX2016002269A (es) 2013-08-21 2014-08-18 Tableta de duloxetina con cubierta enterica.
SG11201600886YA SG11201600886YA (en) 2013-08-21 2014-08-18 Duloxetine enteric coated tablet
AU2014310317A AU2014310317B2 (en) 2013-08-21 2014-08-18 Duloxetine enteric coated tablet
EP14790300.9A EP3035919B1 (en) 2013-08-21 2014-08-18 Duloxetine enteric coated tablet
EA201690368A EA029916B1 (ru) 2013-08-21 2014-08-18 Таблетка дулоксетина с энтеросолюбильным покрытием
MYPI2016000205A MY190111A (en) 2013-08-21 2014-08-18 Duloxetine enteric-coated tablet
HK16112510.8A HK1224197A1 (zh) 2013-08-21 2014-08-18 度洛西汀肠溶包衣片剂
PCT/IB2014/063955 WO2015025261A1 (en) 2013-08-21 2014-08-18 Duloxetine enteric coated tablet
PH12016500245A PH12016500245A1 (en) 2013-08-21 2016-02-04 Duloxetine enteric-coated tablet
ZA2016/01724A ZA201601724B (en) 2013-08-21 2016-03-14 Duloxetine enteric coated tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405111A PL224543B1 (pl) 2013-08-21 2013-08-21 Dojelitowa tabletka duloksetyny

Publications (2)

Publication Number Publication Date
PL405111A1 true PL405111A1 (pl) 2015-03-02
PL224543B1 PL224543B1 (pl) 2017-01-31

Family

ID=52483131

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405111A PL224543B1 (pl) 2013-08-21 2013-08-21 Dojelitowa tabletka duloksetyny

Country Status (12)

Country Link
EP (1) EP3035919B1 (pl)
AU (1) AU2014310317B2 (pl)
EA (1) EA029916B1 (pl)
HK (1) HK1224197A1 (pl)
MX (1) MX2016002269A (pl)
MY (1) MY190111A (pl)
PH (1) PH12016500245A1 (pl)
PL (1) PL224543B1 (pl)
SG (1) SG11201600886YA (pl)
UA (1) UA119852C2 (pl)
WO (1) WO2015025261A1 (pl)
ZA (1) ZA201601724B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007433A (ko) 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
EP1424079A1 (en) 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
CA2651716A1 (en) 2006-05-22 2007-12-06 Gershon Kolatkar Duloxetine hydrochloride delayed release formulations
US20090175935A1 (en) 2006-08-14 2009-07-09 Torrent Research Ltd. Pharmaceutical compositions of duloxetine
EP1938840A1 (en) 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
GB0712220D0 (en) 2007-06-23 2007-08-01 Arrow Int Ltd Duloxetine formulation
WO2009066181A2 (en) 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
CL2008002032A1 (es) 2007-07-13 2009-01-23 Synthon Bv Forma de dosis farmaceutica que posee una pluralidad de pellets, cada pellet comprende, un nucleo de pellet con un diametro de 600 a 1000 micrometros, capa de farmaco que comprende duloxetina o una sal y aglutinante de preferencia metil celulosa, una capa de separacion y una capa de recubrimiento enterico; proceso de preparacion
WO2009087657A2 (en) 2007-11-03 2009-07-16 Alkem Laboratories Ltd. Stable pharmaceutical composition of duloxetine and process for its preparation
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
EP2303244A2 (en) 2008-06-13 2011-04-06 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2010037849A1 (en) 2008-10-02 2010-04-08 Laboratorios Del Dr. Esteve, S.A. Duloxetine enteric pellets
CN101756960B (zh) * 2008-12-26 2012-06-27 上海中西制药有限公司 一种度洛西汀肠溶制剂及其芯材和制备方法

Also Published As

Publication number Publication date
MX2016002269A (es) 2016-06-06
UA119852C2 (uk) 2019-08-27
AU2014310317A1 (en) 2016-03-03
AU2014310317B2 (en) 2019-03-07
EP3035919A1 (en) 2016-06-29
EA029916B1 (ru) 2018-05-31
HK1224197A1 (zh) 2017-08-18
EA201690368A1 (ru) 2016-06-30
EP3035919B1 (en) 2019-10-09
SG11201600886YA (en) 2016-03-30
PH12016500245A1 (en) 2016-05-16
PL224543B1 (pl) 2017-01-31
ZA201601724B (en) 2017-09-27
WO2015025261A1 (en) 2015-02-26
MY190111A (en) 2022-03-29

Similar Documents

Publication Publication Date Title
BR112018010720A2 (pt) agonistas do receptor de apelina e métodos de uso
EA201100978A1 (ru) Схема приема агониста рецептора s1p
BR112014012607A2 (pt) métodos de tratamento usando um inibidor de interferon gama
MX382276B (es) Recubrimientos acuosos de fijado rápido.
BR112018012112A2 (pt) heteroaril-hidroxipirimidinonas como agonistas do receptor apj
EA201792233A8 (ru) Способ уменьшения загрязнения поверхностей
BR112016028639A2 (pt) composição de tintura de cabelo
BR112016020181A8 (pt) composições de ácido lipoico éster colina e métodos de uso.
EA201690036A1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
BR112014032764A2 (pt) composição farmacêutica contendo fimasartana e hidroclorotiazida
BR112015019616A2 (pt) formulação de filtro solar
PH12015502154A1 (en) Composition for oral cavity
MX381478B (es) Composicion dispersante liquida para yeso.
BR112018070547A2 (pt) agonistas de rara para o tratamento de aml e mds
EA201591334A1 (ru) Покрывающие композиции и способы применения
EP2641594A3 (en) Enteric coated solid pharmaceutical compositions for proton pump inhibitors
CR20150275A (es) Composición de difenidol de liberación prolongada
BR112017000211A2 (pt) composição de revestimento estável
IN2015DN01221A (pl)
EA201990093A1 (ru) Двухкомпонентная композиция
PL405111A1 (pl) Dojelitowa tabletka duloksetyny
CL2016001302A1 (es) Hormigón fluido con acelerador secundario
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
MX389143B (es) Metodos de cementacion y composiciones de cemento que contienen lassenite.
EA201991373A1 (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)